BRCA1 mutations in a population-based study of breast cancer in Stockholm county

Genetic Testing

Volumn 8, Issue 2, 2004, Pages 127-132

  Margolin, Sara ^a   Werelius, Barbro ^b   Fornander, Tommy ^a   Lindblom, Annika ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRCA2 GENE; BREAST CANCER; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; ONCOGENE; OVARY CANCER; PEDIGREE; SWEDEN;

ADULT; AGED; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MUTATION; PEDIGREE; RISK FACTORS; SWEDEN;

EID: 4143060219     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/1090657041797365     Document Type: Article

References (28)

1. ANGLICAN BREAST CANCER STUDY GROUP. (2000). Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br. J. Cancer 83, 1301-1308.
2. ANTON-CULVER, H., COHEN, P.F., GILDEA, M.E., et al. (2000). Characteristics of BRCA1 mutations in a population-based case series of breast and ovarial cancer. Eur. J. Cancer 36, 1200-1208.
3. ARVER, B., CLARO, A., LANGEROD, A., et al. (1999). BRCA1 screening in patients with a family history of breast or ovarian cancer. Genet. Test. 3, 223-226.
4. ARVER, B., BORG, A., and LINDBLOM, A. (2001). The first BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet. Test. 5, 1-8.
5. BACKE, J., HOFFERBERT, S., SKAWRAN, B., et al. (1999). Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol. Oncol. 72, 403-406.
6. CHAPPUIS, P.O., HAMEL, N., PARADIS, A.-J., et al. (2001). Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin. Genet. 59, 418-423.
7. CHEN, J., ZELADA HEDMAN, M., WASTESON ARVER, B., et al. (1998). BRCA2 germline mutations in Swedish breast cancer families. Eur. J. Hum. Genet. 6, 134-139.
8. DE LEON MATSUDA, M.L., LIEDE, A., KWAN, E., et al. (2002). BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. Int. J. Cancer 98, 596-603.
9. EINBEIGI, Z., BERGMAN, A., KINDBLOM, L.G., et al. (2001). A founder mutation of the BRCA1 gene in western Sweden associated with a high incidence of breast and ovarian cancer. Eur. J. Cancer 37, 1904-1909.
10. FODOR, F.H., WESTON, A., BLEIWEISS, I.J., et al. (1998). Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients. Am. J. Hum. Genet. 63, 45-51.
11. GARCIA-PATINO, E., GOMENDIO, B., PROVENCIO, M., et al. (1998). Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J. Clin. Oncol. 16, 115-120.
12. HÅKANSSON, S., JOHANNSSON, O., JOHANSON, U., et al. (1997). Moderate frequency of BRCA1 and BRCA2 germline mutations in Scandinavian familial breast cancer. Am. J. Hum. Genet. 60, 1068-1078.
13. HOGERVORST, F.B., CORNELIS, R.S., BOUT, M., et al. (1995). Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genet. 10, 208-212.
14. IAU, P.T.C., MACMILLAN, R.D., and BLAMEY, R.W. (2001). Germ line mutations associated with breast cancer susceptibility. Eur. J. Cancer 37, 300-321.
15. JOHANNSSON, O., OSTERMEYER, F.A., HÅKANSSON, S., et al. (1996). Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am. J. Hum. Genet. 58, 441-450.
16. MIKI, Y., SWENSEN, J., SHATTUCK-EIDENS, D., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71.
17. MØLLER, P., BORG, A., HEIMDAL, K., et al. (2001). The BRCA1 syndrome and other inherited breast and breast-ovarian cancers in a Norwegian prospective series. Eur. J. Cancer 35, 779-781.
18. NEWMAN, B., MU, H., BUTLER, L.M., et al. (1998). Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. J. Am. Med. Assn. 279, 915-921.
19. PAPELARD, H., DE BOCK, G.H., VAN EIJK, R., et al. (2000). Prevalence of BRCA1 in a hospital-based poplation of Dutch breast cancer patients. Br. J. Cancer 83, 719-724.
20. SYRJÄKOSKI, K., VAHTERISTO, P., EEROLA, H., et al. (2000). Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J. Natl. Cancer Inst. 92, 1529.
21. TANG, N.L.S., PANG, C.-P., YEO, W., et al. (1999). Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J. Natl. Cancer Inst. 91, 882-885.
22. THORLACIUS, S., SIGURDSSON, S., BJARNADOTTIR, H., et al. (1997). Study of a single BRCA2 mutation carrier frequency in a small population. Am. J. Hum. Genet. 60, 1079-1084.
23. VAN DER LOOIJ, M., SZABO, C., BESZNYAK, I., et al. (2000). Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int. J. Cancer 86, 737-740.
24. VÅRDPROGRAM BRÖSTCANCER. (2000). Onkologiskt Centrum Stockholm-Gotland.
25. VEHMANEN, P., FRIEDMAN, L.S., EEROLA, H., et al. (1997). Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum. Mol. Genet. 6, 2309-2315.
26. WARNER, E., FOULKES, W., GOODWIN, P., et al. (1999). Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J. Natl. Cancer Inst. 91, 1241-1247.
27. WOOSTER, R., NEUHAUSEN, S.L., MANGION, J., et al. (1994). Localization of a breast cancer susceptibility gene, BRCA 2, to chromosome 13q12-13. Science 265, 2088-2090.
28. ZELADA-HEDMAN, M., WASTESSON ARVER, B., CLARO, A., et al. (1997). A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res. 57, 2474-2477.